Details of the Drug Combinations

General Information of This Drug (ID: DMHKJ5I)

Drug Name

Nabiximols DMHKJ5I

Synonyms

Nabiximols; Sativex; GW-1000; Cannador; Nabiximols [USAN]; GW1000; GW 1000; Tetrahydrocannabinol-cannabidiol combination; Cannabidiol mixture with Tetrahydrocannabinol; delta-9-Tetrahydrocannabinol and cannabidiol; Cannabidiol and delta-9-tetrahydrocarnabinol; GW-1000-02

Indication

Disease Entry	ICD 11	Status	REF
Cancer related pain	MG30	Phase 3	[1]
Muscle spasm	MB47.3	Phase 3	[2]
------------------------------------------------------------------------------------

Drug Type

Small molecular drug

Structure

3D MOL

2D MOL

List of Combinatorial Drugs (CBD) Containing This Drug

1 Clinical Trial Drug Combination(s) Consisting of This drug

DrugCom Name	DrugCom ID	Component Drug	Indication	REF
Nabiximols + Temozolomide	DCQX073	Temozolomide	Glioblastoma	[3]
------------------------------------------------------------------------------------

References

1	Clinical pipeline report, company report or official report of GW Pharmaceuticals.
2	Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
3	ClinicalTrials.gov (NCT05629702) ARISTOCRAT: Blinded Trial of Temozolomide +/- Cannabinoids